Sino Biopharmaceutical's total assets for Q2 2025 were ¥74.89B, a decrease of 0.00% from the previous quarter. DE:SMZ1 total liabilities were ¥29.12B for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.